All Stories

  1. Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression

    Article • ClinicoEconomics and Outcomes Research, March 2019, Dove Medical Press

    Ian Anderson

  2. We all know what we mean by treatment-resistant depression – don't we?

    Article • The British Journal of Psychiatry, April 2018, Royal College of Psychiatrists

    Ian Anderson

  3. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial

    Article • The Lancet Psychiatry, May 2017, Elsevier

    Ian Anderson

  4. Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression

    Article • Molecular Psychiatry, April 2017, Springer Science + Business Media

    Ian Anderson, Professor Marcus R Munafo, Prof Kaarin J Anstey

  5. Variants in theCNR1gene predispose to headache with nausea in the presence of life stress

    Article • Genes Brain & Behavior, November 2016, Wiley

    Ian Anderson

  6. Unipolar depressive disorders

    Article • Medicine, November 2016, Elsevier

    Ian Anderson

  7. Rumination in migraine: Mediating effects of brooding and reflection between migraine and psychological distress

    Article • Psychology & Health, September 2016, Taylor & Francis

    Ian Anderson

  8. Financial difficulties but not other types of recent negative life events show strong interactions with 5-HTTLPR genotype in the development of depressive symptoms

    Article • Translational Psychiatry, May 2016, Nature

    Ian Anderson

  9. Distinct effects of folate pathway genes MTHFR and MTHFD1L on ruminative response style: a potential risk mechanism for depression

    Article • Translational Psychiatry, March 2016, Nature

    Ian Anderson

  10. Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial

    Article • Current Controlled Trials in Cardiovascular Medicine, February 2016, Springer Science + Business Media

    Ian Anderson

  11. Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial

    Article • The Lancet Psychiatry, February 2016, Elsevier

    Ian Anderson

  12. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)

    Article • BMC Psychiatry, October 2015, Springer Science + Business Media

    Ian Anderson

  13. New approaches to treating resistant depression

    Article • BJPsych Advances, September 2015, Royal College of Psychiatrists

    Ian Anderson

  14. Managing inadequate antidepressant response in depressive illness

    Article • British Medical Bulletin, August 2015, Oxford University Press (OUP)

    Ian Anderson

  15. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

    Article • Journal of Psychopharmacology, May 2015, SAGE Publications

    Ian Anderson

  16. Variability in the Effect of 5-HTTLPR on Depression in a Large European Population: The Role of Age, Symptom Profile, Type and Intensity of Life Stressors

    Article • PLoS ONE, March 2015, PLOS

    Ian Anderson

  17. Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials

    Article • Bipolar Disorders, January 2015, Wiley

    Ian Anderson

  18. Social-economical decision making in current and remitted major depression

    Article • Psychological Medicine, October 2014, Cambridge University Press

    Ian Anderson

  19. Neuronal Nitric Oxide Synthase (NOS1) Polymorphisms Interact with Financial Hardship to Affect Depression Risk

    Article • Neuropsychopharmacology, June 2014, Nature

    Ian Anderson

  20. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

    Article • Journal of Psychopharmacology, April 2014, SAGE Publications

    Ian Anderson

  21. Brain galanin system genes interact with life stresses in depression-related phenotypes

    Article • Proceedings of the National Academy of Sciences, March 2014, Proceedings of the National Academy of Sciences

    Ian Anderson

  22. TOMM40 rs2075650 May Represent a New Candidate Gene for Vulnerability to Major Depressive Disorder

    Article • Neuropsychopharmacology, January 2014, Nature

    Ian Anderson

  23. Enhanced subgenual cingulate response to altruistic decisions in remitted major depressive disorder

    Article • NeuroImage Clinical, January 2014, Elsevier

    Ian Anderson

  24. Temporal discounting in major depressive disorder

    Article • Psychological Medicine, November 2013, Cambridge University Press

    Ian Anderson

  25. Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)

    Article • BMC Psychiatry, August 2013, Springer Science + Business Media

    Ian Anderson

  26. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

    Article • The World Journal of Biological Psychiatry, July 2013, Taylor & Francis

    Ian Anderson

  27. Staying well has to be the main goal

    Article • BMJ, April 2013, BMJ

    Ian Anderson

  28. Detection of the acute effects of hydrocortisone in the hippocampus using pharmacological fMRI

    Article • European Neuropsychopharmacology, December 2012, Elsevier

    Ian Anderson

  29. State-dependent changes in hippocampal grey matter in depression

    Article • Molecular Psychiatry, November 2012, Nature

    Ian Anderson

  30. Unipolar depression and dysthymia

    Article • Medicine, November 2012, Elsevier

    Ian Anderson

  31. Reversed Frontotemporal Connectivity During Emotional Face Processing in Remitted Depression

    Article • Biological Psychiatry, October 2012, Elsevier

    Ian Anderson

  32. Genetic variants in the catechol-o-methyltransferase gene are associated with impulsivity and executive function: Relevance for major depression

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, September 2012, Wiley

    Ian Anderson

  33. Increased Amygdala Responses to Sad But Not Fearful Faces in Major Depression: Relation to Mood State and Pharmacological Treatment

    Article • American Journal of Psychiatry, August 2012, American Psychiatric Association

    Ian Anderson

  34. TREAD adds little to the evidence

    Article • BMJ, July 2012, BMJ

    Ian Anderson

  35. Bipolar disorder

    Article • BMJ, April 2012, BMJ

    Ian Anderson

  36. Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses

    Article • European Neuropsychopharmacology, January 2012, Elsevier

    Professor Marcus R Munafo, Ian Anderson

  37. Pharmacological Treatment of Unipolar Depression

    Article • January 2012, Springer Science + Business Media

    Ian Anderson

  38. Reduced Medial Prefrontal Responses to Social Interaction Images in Remitted Depression

    Article • Archives of General Psychiatry, January 2012, American Medical Association (AMA)

    Ian Anderson

  39. Mirtazapine antagonises the subjective, hormonal and neuronal effects of m-chlorophenylpiperazine (mCPP) infusion: A pharmacological-challenge fMRI (phMRI) study

    Article • NeuroImage, September 2011, Elsevier

    Ian Anderson

  40. Neural correlates of choice behavior related to impulsivity and venturesomeness

    Article • Neuropsychologia, July 2011, Elsevier

    Ian Anderson

  41. Bad medicine or bad mouthing?

    Article • BMJ, May 2011, BMJ

    Ian Anderson

  42. State-dependent alteration in face emotion recognition in depression

    Article • The British Journal of Psychiatry, April 2011, Royal College of Psychiatrists

    Ian Anderson

  43. The CREB1-BDNF-NTRK2 Pathway in Depression: Multiple Gene-Cognition-Environment Interactions

    Article • Biological Psychiatry, April 2011, Elsevier

    Ian Anderson

  44. No medication without representation? Generalizing from antidepressant clinical efficacy trials to clinical practice

    Article • Psychological Medicine, March 2011, Cambridge University Press

    Ian Anderson

  45. Interaction between a history of depression and rumination on neural response to emotional faces

    Article • Psychological Medicine, February 2011, Cambridge University Press

    Ian Anderson

  46. Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionality

    Article • European Neuropsychopharmacology, January 2011, Elsevier

    Ian Anderson

  47. NewMood: A productive European model of collaboration for translational research in depression

    Article • European Neuropsychopharmacology, January 2011, Elsevier

    Ian Anderson

  48. Prescribing antidepressants for depression: time to be dimensional and inclusive

    Article • British Journal of General Practice, January 2011, Royal College of General Practitioners

    Ian Anderson

  49. The HTR1A and HTR1B receptor genes influence stress-related information processing

    Article • European Neuropsychopharmacology, January 2011, Elsevier

    Ian Anderson

  50. The effect of acute citalopram on face emotion processing in remitted depression: A pharmacoMRI study

    Article • European Neuropsychopharmacology, January 2011, Elsevier

    Ian Anderson

  51. Choice between reinforcer delays versus choice between reinforcer magnitudes: Differential Fos expression in the orbital prefrontal cortex and nucleus accumbens core

    Article • Behavioural Brain Research, December 2010, Elsevier

    Ian Anderson

  52. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial

    Article • Health Technology Assessment, September 2010, National Institute for Health Research

    Ian Anderson

  53. Continuation and maintenance treatment

    Article • August 2010, Springer Science + Business Media

    Ian Anderson

  54. Management of treatment nonresponse

    Article • August 2010, Springer Science + Business Media

    Ian Anderson

  55. Medications

    Article • August 2010, Springer Science + Business Media

    Ian Anderson

  56. Principles of therapy

    Article • August 2010, Springer Science + Business Media

    Ian Anderson

  57. Attenuated responses to emotional expressions in women with generalized anxiety disorder

    Article • Psychological Medicine, August 2010, Cambridge University Press

    Ian Anderson

  58. Affective Cognition and its Disruption in Mood Disorders

    Article • Neuropsychopharmacology, June 2010, Nature

    Ian Anderson

  59. The effects of real versus hypothetical reward on delay and probability discounting

    Article • Quarterly Journal of Experimental Psychology, June 2010, SAGE Publications

    Ian Anderson

  60. A comparison of permutation and parametric testing for between group effective connectivity differences using DCM

    Article • NeuroImage, April 2010, Elsevier

    Ian Anderson

  61. Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individuals

    Article • Journal of Psychiatric Research, February 2010, Elsevier

    Ian Anderson

  62. Managing Depression in Clinical Practice

    Article • January 2010, Springer Science + Business Media

    Ian Anderson

  63. Risk-Taking Behavior in a Gambling Task Associated with Variations in the Tryptophan Hydroxylase 2 Gene: Relevance to Psychiatric Disorders

    Article • Neuropsychopharmacology, December 2009, Nature

    Ian Anderson

  64. Corrigendum to “Effects of lesions of the nucleus accumbens core on inter-temporal choice: Further observations with an adjusting-delay procedure” [Behav. Brain Res. 202 (2009) 272–277]

    Article • Behavioural Brain Research, November 2009, Elsevier

    Ian Anderson

  65. Diminished Neural and Cognitive Responses to Facial Expressions of Disgust in Patients with Psoriasis: A Functional Magnetic Resonance Imaging Study

    Article • Journal of Investigative Dermatology, November 2009, Elsevier

    Ian Anderson

  66. Erratum

    Article • Journal of Psychopharmacology, November 2009, SAGE Publications

    Ian Anderson

  67. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients

    Article • Journal of Affective Disorders, November 2009, Elsevier

    Ian Anderson

  68. Depression in adults, including those with a chronic physical health problem: summary of NICE guidance

    Article • BMJ, October 2009, BMJ

    Ian Anderson

  69. CANMAT Guidelines for depression: Clear and user-friendly

    Article • Journal of Affective Disorders, October 2009, Elsevier

    Ian Anderson

  70. Effects of lesions of the nucleus accumbens core on inter-temporal choice: Further observations with an adjusting-delay procedure

    Article • Behavioural Brain Research, September 2009, Elsevier

    Ian Anderson

  71. Significant association between the C(−1019)G functional polymorphism of the HTR1A gene and impulsivity

    Article • American Journal of Medical Genetics Part B Neuropsychiatric Genetics, September 2009, Wiley

    Ian Anderson

  72. Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: An open-label, pilot study

    Article • Journal of Affective Disorders, September 2009, Elsevier

    Ian Anderson

  73. Quantitative analysis of the effect of lesions of the subthalamic nucleus on intertemporal choice: further evidence for enhancement of the incentive value of food reinforcers

    Article • Behavioural Pharmacology, September 2009, Wolters Kluwer Health

    Ian Anderson

  74. Variations in the cannabinoid receptor 1 gene predispose to migraine

    Article • Neuroscience Letters, September 2009, Elsevier

    Ian Anderson

  75. Commentary on STAR*D: a summary and UK perspective

    Article • Journal of Psychopharmacology, April 2009, SAGE Publications

    Ian Anderson

  76. CNR1 Gene is Associated with High Neuroticism and Low Agreeableness and Interacts with Recent Negative Life Events to Predict Current Depressive Symptoms

    Article • Neuropsychopharmacology, February 2009, Nature

    Ian Anderson

  77. A survey of the teaching and assessment of undergraduate psychiatry in the medical schools of the United Kingdom and Ireland

    Article • Medical Teacher, January 2009, Taylor & Francis

    Ian Anderson

  78. Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1ª parte: tratamento agudo e de continuação do transtorno depressivo maior

    Article • Archives of Clinical Psychiatry (São Paulo), January 2009, FapUNIFESP (SciELO)

    Ian Anderson

  79. Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 2ª parte: tratamento de manutenção do transtorno depressivo maior e tratamento dos transtornos depressivos crô...

    Article • Archives of Clinical Psychiatry (São Paulo), January 2009, FapUNIFESP (SciELO)

    Ian Anderson

  80. Effect of quinolinic acid-induced lesions of the subthalamic nucleus on performance on a progressive-ratio schedule of reinforcement: A quantitative analysis

    Article • Behavioural Brain Research, December 2008, Elsevier

    Ian Anderson

  81. Assessing human 5-HT function in vivo with pharmacoMRI

    Article • Neuropharmacology, November 2008, Elsevier

    Ian Anderson

  82. Validation of the Mood Disorder Questionnaire for screening for bipolar disorder in a UK sample

    Article • Journal of Affective Disorders, September 2008, Elsevier

    Ian Anderson

  83. Effect of disconnecting the orbital prefrontal cortex from the nucleus accumbens core on inter-temporal choice behaviour: A quantitative analysis

    Article • Behavioural Brain Research, August 2008, Elsevier

    Ian Anderson

  84. BAP depression guidelines put antidepressant treatment in context

    Article • Progress in Neurology and Psychiatry, July 2008, Wiley

    Ian Anderson

  85. ECNP consensus meeting. Bipolar depression. Nice, March 2007

    Article • European Neuropsychopharmacology, July 2008, Elsevier

    Ian Anderson

  86. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

    Article • Journal of Psychopharmacology, April 2008, SAGE Publications

    Ian Anderson

  87. The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study

    Article • Journal of Psychopharmacology, February 2008, SAGE Publications

    Ian Anderson

  88. Effect of quinolinic acid-induced lesions of the nucleus accumbens core on performance on a progressive ratio schedule of reinforcement: implications for inter-temporal choice

    Article • Psychopharmacology, January 2008, Springer Science + Business Media

    Ian Anderson

  89. Recognising and managing antidepressant discontinuation symptoms

    Article • Advances in Psychiatric Treatment, November 2007, Cambridge University Press

    Ian Anderson

  90. Commentary on ‘Re-evaluation of the efficacy and tolerability of venlafaxine versus SSRI: meta-analysis’ by Weinmann et al.

    Article • Psychopharmacology, October 2007, Springer Science + Business Media

    Ian Anderson

  91. Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study

    Article • Neuroreport, August 2007, Wolters Kluwer Health

    Ian Anderson

  92. Effects of quinolinic acid-induced lesions of the nucleus accumbens core on inter-temporal choice: a quantitative analysis

    Article • Psychopharmacology, July 2007, Springer Science + Business Media

    Ian Anderson

  93. Adjunctive fast repetitive transcranial magnetic stimulation in depression

    Article • The British Journal of Psychiatry, June 2007, Royal College of Psychiatrists

    Ian Anderson

  94. Development and validation of the Generalized Anxiety Disorder Inventory (GADI)

    Article • Journal of Psychopharmacology, March 2007, SAGE Publications

    Professor Sean D Hood, Ian Anderson

  95. Service innovations: developing a specialised (tertiary) service for the treatment of affective disorders

    Article • Psychiatric Bulletin, March 2006, Royal College of Psychiatrists

    Ian Anderson

  96. Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers

    Article • European Journal of Neuroscience, January 2006, Wiley

    Ian Anderson

  97. The new guidelines from the British Association for Psychopharmacology for anxiety disorders

    Article • International Journal of Psychiatry in Clinical Practice, January 2006, Taylor & Francis

    Ian Anderson

  98. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

    Article • Journal of Psychopharmacology, November 2005, SAGE Publications

    Ian Anderson

  99. Acute tryptophan or tyrosine depletion test: time for reappraisal?

    Article • Journal of Psychopharmacology, July 2005, SAGE Publications

    Ian Anderson

  100. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?

    Article • Journal of Psychopharmacology, July 2005, SAGE Publications

    Ian Anderson

  101. Reply to Abdulla A.-B. Badawy - Acute tryptophan or tyrosine depletion test: time for reappraisal?

    Article • Journal of Psychopharmacology, July 2005, SAGE Publications

    Ian Anderson

  102. Neuronal effects of acute citalopram detected by pharmacoMRI

    Article • Psychopharmacology, May 2005, Springer Science + Business Media

    Ian Anderson

  103. The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study

    Article • Neuropsychopharmacology, April 2005, Nature

    Ian Anderson

  104. Making decisions in the absence of high quality clinical evidence: we need to bring some science into the judgement

    Article • Journal of Psychopharmacology, March 2005, SAGE Publications

    Ian Anderson

  105. Effect of acute tryptophan depletion on the response to controllable and uncontrollable noise stress

    Article • Biological Psychiatry, February 2005, Elsevier

    Ian Anderson

  106. The effect of orbital prefrontal cortex lesions on performance on a progressive ratio schedule: implications for models of inter-temporal choice

    Article • Behavioural Brain Research, January 2005, Elsevier

    Ian Anderson

  107. Lack of behavioural effects after acute tyrosine depletion in healthy volunteers

    Article • Journal of Psychopharmacology, January 2005, SAGE Publications

    Ian Anderson

  108. Changes in Pharmacological treatment for Bipolar Disorder Over Time in Manchester: A Comparison with Lloyd et al. (2003)

    Article • Journal of Psychopharmacology, September 2004, SAGE Publications

    Ian Anderson

  109. Drug Information Not Regulation is Needed

    Article • Journal of Psychopharmacology, March 2004, SAGE Publications

    Ian Anderson

  110. Management of diabetes mellitus occurring during treatment with olanzapine: report of six cases and clinical implications

    Article • Journal of Psychopharmacology, March 2004, SAGE Publications

    Ian Anderson

  111. Neurobiological substrates of antisocial and borderline personality disorder: preliminary results of a functional fMRI study

    Article • Criminal Behaviour and Mental Health, March 2004, Wiley

    Ian Anderson

  112. Reproducibility of Negative Mood Induction: a Self-Referent Plus Musical Mood Induction Procedure and a Controllable/Uncontrollable Stress Paradigm

    Article • Journal of Psychopharmacology, March 2004, SAGE Publications

    Ian Anderson

  113. Effects of orbital prefrontal cortex dopamine depletion on inter-temporal choice: a quantitative analysis

    Article • Psychopharmacology, February 2004, Springer Science + Business Media

    Ian Anderson

  114. Role of the orbital prefrontal cortex in choice between delayed and uncertain reinforcers: a quantitative analysis

    Article • Behavioural Processes, October 2003, Elsevier

    Ian Anderson

  115. Clinical trials of antidepressant medications are producing meaningless results

    Article • The British Journal of Psychiatry, August 2003, Royal College of Psychiatrists

    Ian Anderson

  116. The antidepressant debate should move on

    Article • The British Journal of Psychiatry, June 2003, Royal College of Psychiatrists

    Ian Anderson

  117. The Relationship between Serotonergic Function and the Psychopathy Checklist: Screening Version

    Article • Journal of Psychopharmacology, June 2003, SAGE Publications

    Ian Anderson

  118. Drug treatment of depression: reflections on the evidence

    Article • Advances in Psychiatric Treatment, January 2003, Cambridge University Press

    Ian Anderson

  119. The effect of acute tryptophan depletion on probabilistic choice

    Article • Journal of Psychopharmacology, January 2003, SAGE Publications

    Ian Anderson

  120. Effects of quinolinic acid-induced lesions of the orbital prefrontal cortex on inter-temporal choice: a quantitative analysis

    Article • Psychopharmacology, December 2002, Springer Science + Business Media

    Ian Anderson

  121. Quantitative frontal and temporal structural MRI studies in personality-disordered offenders and control subjects

    Article • Psychiatry Research Neuroimaging, December 2002, Elsevier

    Ian Anderson

  122. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis

    Article • The British Journal of Psychiatry, May 2002, Royal College of Psychiatrists

    Ian Anderson, Ms Julie Glanville

  123. Effects of lesions of the orbitofrontal cortex on sensitivity to delayed and probabilistic reinforcement

    Article • Psychopharmacology, March 2002, Springer Science + Business Media

    Ian Anderson

  124. Executive and memory function and its relationship to trait impulsivity and aggression in personality disordered offenders

    Article • Journal of Forensic Psychiatry, January 2002, Taylor & Francis

    Ian Anderson

  125. Guidelines for choice of selective serotonin reuptake inhibitor in depressive illness

    Article • Advances in Psychiatric Treatment, May 2001, Cambridge University Press

    Ian Anderson

  126. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders

    Article • The British Journal of Psychiatry, April 2001, Royal College of Psychiatrists

    Ian Anderson

  127. Meta-analytical studies on new antidepressants

    Article • British Medical Bulletin, March 2001, Oxford University Press (OUP)

    Ian Anderson

  128. Treatment of bipolar affective disorder in clinical practice

    Article • Journal of Psychopharmacology, January 2001, SAGE Publications

    Ian Anderson

  129. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs: Meta-regression analysis

    Article • The British Journal of Psychiatry, October 2000, Royal College of Psychiatrists

    Ian Anderson

  130. d -Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine

    Article • Psychopharmacology, April 2000, Springer Science + Business Media

    Ian Anderson

  131. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability

    Article • Journal of Affective Disorders, April 2000, Elsevier

    Ian Anderson

  132. Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteers

    Article • The British Journal of Psychiatry, February 2000, Royal College of Psychiatrists

    Ian Anderson

  133. More people with depression continued treatment with fluoxetine than with desipramine or imipramine

    Article • Evidence-Based Mental Health, February 2000, BMJ

    Ian Anderson

  134. The new antidepressants

    Article • Current Anaesthesia and Critical Care, February 1999, Elsevier

    Ian Anderson

  135. Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors

    Article • Drugs, January 1999, Springer Science + Business Media

    Ian Anderson

  136. Information processing in anxiety: a pilot study of the effect of manipulating 5-HT function

    Article • Journal of Psychopharmacology, March 1998, SAGE Publications

    Ian Anderson

  137. The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers

    Article • Psychopharmacology, November 1996, Springer Science + Business Media

    Ian Anderson

  138. Place of tricyclics in depression of young people is not proved

    Article • BMJ, August 1995, BMJ

    Ian Anderson

  139. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

    Article • BMJ, June 1995, BMJ

    Ian Anderson

  140. A meta-analysis of the efficacy of selective serotonin reuptake inhibitors compared to tricyclic antidepressants in depression

    Article • European Neuropsychopharmacology, September 1994, Elsevier

    Ian Anderson

  141. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

    Article • Journal of Psychopharmacology, July 1994, SAGE Publications

    Ian Anderson

  142. Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers

    Article • Psychopharmacology, March 1992, Springer Science + Business Media

    Ian Anderson

  143. Prolactin response to the dopamine antagonist, metoclopramide, in depression

    Article • Biological Psychiatry, August 1991, Elsevier

    Ian Anderson

  144. Abnormal 5-HT neuroendocrine function in depression: association or artefact?

    Article • February 1991, Oxford University Press (OUP)

    Ian Anderson

  145. Decreased plasma tryptophan concentration in major depression: relationship to melancholia and weight loss

    Article • Journal of Affective Disorders, November 1990, Elsevier

    Ian Anderson

  146. Dieting reduces plasma tryptophan and alters brain 5-HT function in women

    Article • Psychological Medicine, November 1990, Cambridge University Press

    Ian Anderson

  147. Endocrinological Responses to 5-HT

    Article • Annals of the New York Academy of Sciences, October 1990, Wiley

    Ian Anderson

  148. The effects of gepirone on neuroendocrine function and temperature in humans

    Article • Psychopharmacology, April 1990, Springer Science + Business Media

    Ian Anderson

  149. Metergoline abolishes the prolactin response to buspirone

    Article • Psychopharmacology, February 1990, Springer Science + Business Media

    Ian Anderson

  150. SEROTONIN RECEPTORS, BUSPIRONE, AND PREMENSTRUAL SYNDROME

    Article • The Lancet, September 1989, Elsevier

    Ian Anderson

  151. Effect of moderate weight loss on prolactin secretion in normal female volunteers

    Article • Psychiatry Research, August 1989, Elsevier

    Ian Anderson

  152. The effect of moderate weight loss on overnight growth hormone and cortisol secretion in healthy female volunteers

    Article • Journal of Affective Disorders, March 1989, Elsevier

    Ian Anderson

  153. L-Tryptophan and prolactin release: Evidence for interaction between 5-HT1 and 5-HT2 receptors

    Article • Human Psychopharmacology Clinical and Experimental, December 1986, Wiley

    Ian Anderson

  154. Clomipramine enhances prolactin and growth hormone responses to l-tryptophan

    Article • Psychopharmacology, May 1986, Springer Science + Business Media

    Ian Anderson

  155. Pharmacological Treatments for Worry: Focus on Generalised Anxiety Disorder

    Article • Wiley

    Ian Anderson